Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C19H17NO7 |
| Molecular Weight | 371.3408 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 3 / 3 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
NC(=O)C1=C(O)C[C@@H]2C[C@@H]3CC4=C(C(O)=CC=C4)C(=O)C3=C(O)[C@]2(O)C1=O
InChI
InChIKey=ZXFCRFYULUUSDW-OWXODZSWSA-N
InChI=1S/C19H17NO7/c20-18(26)14-11(22)6-9-5-8-4-7-2-1-3-10(21)12(7)15(23)13(8)16(24)19(9,27)17(14)25/h1-3,8-9,21-22,24,27H,4-6H2,(H2,20,26)/t8-,9-,19-/m0/s1
| Molecular Formula | C19H17NO7 |
| Molecular Weight | 371.3408 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 3 / 3 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Iincyclinide, also known as CMT-3 and COL-3, is an MMP inhibitor and a chemically-modified tetracycline with potential antineoplastic activity patented by Chas. Pfizer & Co. Incyclinide has been shown to experimentally suppress prostate cancer, colon adenocarcinoma and melanoma invasiveness in cell culture. Incyclinide is an especially effective inhibitor of the growth and viability of filamentous fungi. Unfortunately, in clinical trials, Iincyclinide failed to demonstrate efficacy in Lymphoma, Melanoma, Renal Cell Carcinoma, and some other tumors.
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL3869 Sources: https://www.ncbi.nlm.nih.gov/pubmed/11172680 |
|||
Target ID: CHEMBL321 Sources: https://www.ncbi.nlm.nih.gov/pubmed/16242193 |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Chemically modified tetracyclines induce apoptosis in cultured mast cells. | 2005-10 |
|
| Chemically modified tetracycline (CMT)-3 inhibits histamine release and cytokine production in mast cells: possible involvement of protein kinase C. | 2005-07 |
|
| Effect of chemically modified tetracycline on transforming growth factor-beta1 and caspase-3 activation in liver of septic rats. | 2005-07 |
|
| Cyclooxygenase-2 inhibitor celecoxib augments chemotherapeutic drug-induced apoptosis by enhancing activation of caspase-3 and -9 in prostate cancer cells. | 2005-06-20 |
|
| Role of chemically modified tetracycline on TNF-alpha and mitogen-activated protein kinases in sepsis. | 2004-11 |
|
| A nonantibiotic chemically modified tetracycline (CMT-3) inhibits intimal thickening. | 2003-10 |
|
| Inhibition of cell proliferation, invasion, tumor growth and metastasis by an oral non-antimicrobial tetracycline analog (COL-3) in a metastatic prostate cancer model. | 2002-03-10 |
|
| Reversible sideroblastic anemia associated with the tetracycline analogue COL-3. | 2001-05 |
|
| Cytotoxic activity and inhibition of tumor cell invasion by derivatives of a chemically modified tetracycline CMT-3 (COL-3). | 2001-02 |
|
| CMT-3, a non-antimicrobial tetracycline (TC), inhibits MT1-MMP activity: relevance to cancer. | 2001-02 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://clinicaltrials.gov/ct2/show/NCT00020683
50 mg/day and 100 mg/day
Route of Administration:
Oral
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 21:22:52 GMT 2025
by
admin
on
Mon Mar 31 21:22:52 GMT 2025
|
| Record UNII |
21G64WZQ4I
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C1970
Created by
admin on Mon Mar 31 21:22:52 GMT 2025 , Edited by admin on Mon Mar 31 21:22:52 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
683551
Created by
admin on Mon Mar 31 21:22:52 GMT 2025 , Edited by admin on Mon Mar 31 21:22:52 GMT 2025
|
PRIMARY | |||
|
Incyclinide
Created by
admin on Mon Mar 31 21:22:52 GMT 2025 , Edited by admin on Mon Mar 31 21:22:52 GMT 2025
|
PRIMARY | |||
|
RR-11
Created by
admin on Mon Mar 31 21:22:52 GMT 2025 , Edited by admin on Mon Mar 31 21:22:52 GMT 2025
|
PRIMARY | |||
|
C2454
Created by
admin on Mon Mar 31 21:22:52 GMT 2025 , Edited by admin on Mon Mar 31 21:22:52 GMT 2025
|
PRIMARY | |||
|
54678924
Created by
admin on Mon Mar 31 21:22:52 GMT 2025 , Edited by admin on Mon Mar 31 21:22:52 GMT 2025
|
PRIMARY | |||
|
CHEMBL2104970
Created by
admin on Mon Mar 31 21:22:52 GMT 2025 , Edited by admin on Mon Mar 31 21:22:52 GMT 2025
|
PRIMARY | |||
|
15866-90-7
Created by
admin on Mon Mar 31 21:22:52 GMT 2025 , Edited by admin on Mon Mar 31 21:22:52 GMT 2025
|
PRIMARY | |||
|
300000034248
Created by
admin on Mon Mar 31 21:22:52 GMT 2025 , Edited by admin on Mon Mar 31 21:22:52 GMT 2025
|
PRIMARY | |||
|
DTXSID801032905
Created by
admin on Mon Mar 31 21:22:52 GMT 2025 , Edited by admin on Mon Mar 31 21:22:52 GMT 2025
|
PRIMARY | |||
|
21G64WZQ4I
Created by
admin on Mon Mar 31 21:22:52 GMT 2025 , Edited by admin on Mon Mar 31 21:22:52 GMT 2025
|
PRIMARY | |||
|
8698
Created by
admin on Mon Mar 31 21:22:52 GMT 2025 , Edited by admin on Mon Mar 31 21:22:52 GMT 2025
|
PRIMARY | |||
|
DB11647
Created by
admin on Mon Mar 31 21:22:52 GMT 2025 , Edited by admin on Mon Mar 31 21:22:52 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |